Clinical Trial Update: MYOHEART™ (Myogenesis Heart Efficiency and Regeneration Trial) [Phase 1]

View source ↗

Summary

Phase 1 trial update for MYOHEART, Bioheart’s investigational therapy for heart disease; the trial status is currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Heart Failure
• Myocardial Infarction

Drugs mentioned

• MYOHEART

Snippet

Sponsor: Bioheart, Inc. | Conditions: Congestive Heart Failure, Coronary Artery Disease | Phase 1 | Status: UNKNOWN